X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (351) 351
Publication (47) 47
Book Chapter (9) 9
Book Review (4) 4
Newspaper Article (4) 4
Book / eBook (2) 2
Newsletter (2) 2
Web Resource (2) 2
Magazine Article (1) 1
Report (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (229) 229
index medicus (224) 224
administration, oral (180) 180
pharmacology & pharmacy (166) 166
influenza (126) 126
animals (119) 119
oseltamivir (116) 116
male (113) 113
female (107) 107
antiviral agents - administration & dosage (96) 96
influenza, human - drug therapy (88) 88
adult (81) 81
antiviral agents - therapeutic use (73) 73
neuraminidase - antagonists & inhibitors (68) 68
mice (65) 65
oseltamivir - administration & dosage (65) 65
pharmacokinetics (60) 60
infectious diseases (54) 54
viruses (54) 54
antiviral agents (53) 53
oral oseltamivir (52) 52
antiviral agents - pharmacology (51) 51
zanamivir (50) 50
middle aged (49) 49
child (45) 45
efficacy (45) 45
health aspects (45) 45
antiviral agents - pharmacokinetics (44) 44
adolescent (43) 43
in-vitro (43) 43
microbiology (43) 43
treatment outcome (42) 42
safety (41) 41
children (39) 39
virology (39) 39
influenza, human - virology (38) 38
young adult (37) 37
orthomyxoviridae infections - drug therapy (36) 36
aged (34) 34
dose-response relationship, drug (33) 33
immunology (33) 33
neuraminidase inhibitors (33) 33
oseltamivir - therapeutic use (32) 32
chemistry, medicinal (30) 30
drug therapy (30) 30
infection (30) 30
oseltamivir - pharmacology (30) 30
analysis (29) 29
biological availability (29) 29
infections (29) 29
influenza a virus - drug effects (29) 29
neuraminidase inhibitor (29) 29
randomized controlled-trial (29) 29
virus diseases (29) 29
antiviral agents - adverse effects (28) 28
oseltamivir - pharmacokinetics (28) 28
influenza, human - prevention & control (27) 27
medicine, general & internal (27) 27
research (27) 27
dogs (26) 26
drugs (26) 26
oseltamivir phosphate (26) 26
double-blind method (25) 25
absorption (24) 24
child, preschool (24) 24
infant (24) 24
neuraminidase inhibitor oseltamivir (24) 24
influenza a virus, h1n1 subtype - drug effects (23) 23
oral administration (23) 23
virus (23) 23
mice, inbred balb c (22) 22
permeability (22) 22
pharmacology (22) 22
pharmacology/toxicology (22) 22
rats (22) 22
acetamides - administration & dosage (21) 21
bioavailability (21) 21
enzyme inhibitors - pharmacology (21) 21
enzyme inhibitors - therapeutic use (21) 21
medicine (21) 21
time factors (21) 21
acetamides - therapeutic use (20) 20
antiviral (20) 20
article (20) 20
chemistry, multidisciplinary (20) 20
disease models, animal (20) 20
drug resistance, viral (20) 20
enzyme inhibitors - administration & dosage (20) 20
influenza b virus - drug effects (20) 20
models, biological (20) 20
resistance (20) 20
a virus (19) 19
administration, inhalation (19) 19
guanidines (19) 19
orthomyxoviridae infections - virology (19) 19
pharmacy (19) 19
research article (19) 19
area under curve (18) 18
biomedicine (18) 18
dosage and administration (18) 18
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (362) 362
Japanese (4) 4
German (3) 3
Russian (3) 3
Portuguese (2) 2
Arabic (1) 1
Chinese (1) 1
French (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal of Postgraduate Medicine, ISSN 0022-3859, 12/2009, Volume 55, Issue 3, pp. 225 - 230
Journal Article
Journal of Infectious Diseases, ISSN 0022-1899, 03/2013, Volume 207, Issue 5, pp. 709 - 720
Journal Article
Journal Article
Journal Article
Journal of Medicinal Chemistry, ISSN 0022-2623, 10/2012, Volume 55, Issue 20, pp. 8657 - 8670
Oseltamivir phosphonic acid (tamiphosphor, 3a), its monoethyl ester (3c), guanidino-tamiphosphor (4a), and its monoethyl ester (4c) are potent inhibitors of... 
INTESTINAL-ABSORPTION | IN-VITRO | CHEMISTRY, MEDICINAL | THERAPY | ACID | PRODRUG | ZANAMIVIR | A VIRUSES | INFLUENZA-VIRUS NEURAMINIDASE | INHIBITORS | GUANIDINO-OSELTAMIVIR | Influenza A Virus, H5N1 Subtype - enzymology | Cytopathogenic Effect, Viral - drug effects | Influenzavirus B - drug effects | Antiviral Agents - pharmacokinetics | Humans | Microsomes, Liver - metabolism | Drug Resistance, Viral | Acetamides - pharmacology | Biological Availability | Male | Structure-Activity Relationship | Blood Proteins - metabolism | Influenzavirus A - enzymology | Acetamides - chemical synthesis | Madin Darby Canine Kidney Cells | Female | Influenza A Virus, H1N1 Subtype - genetics | Influenzavirus A - genetics | Orthomyxoviridae Infections - drug therapy | Oseltamivir - pharmacology | Antiviral Agents - pharmacology | Acetamides - pharmacokinetics | Administration, Oral | Drug Stability | Cyclohexenes - pharmacokinetics | Rats | Cyclohexenes - chemical synthesis | Influenza A Virus, H5N1 Subtype - drug effects | Influenza A Virus, H1N1 Subtype - drug effects | Influenzavirus A - drug effects | Animals | Influenzavirus B - enzymology | Influenza A Virus, H1N1 Subtype - enzymology | Dogs | Antiviral Agents - chemical synthesis | Cyclohexenes - pharmacology | Protein Binding | Neuraminidase - antagonists & inhibitors | Mice | Mice, Inbred BALB C | Mutation | Phosphorous Acids
Journal Article
Journal of Medicinal Chemistry, ISSN 0022-2623, 02/2014, Volume 57, Issue 3, pp. 759 - 769
Journal Article
Antimicrobial Agents and Chemotherapy, ISSN 0066-4804, 03/2009, Volume 53, Issue 3, pp. 945 - 952
Journal Article
Clinical Pharmacokinetics, ISSN 0312-5963, 9/2011, Volume 50, Issue 9, pp. 613 - 623
Journal Article
Drug Design, Development and Therapy, ISSN 1177-8881, 03/2017, Volume 11, pp. 705 - 711
Journal Article